- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03161665
Patient and Caregiver Participation Through an Educational Health Information Technology System ("BMT Roadmap") in the Context of Hematopoietic Cell Transplantation
A Pilot Study of Patient and Caregiver Participation Through an Educational Health Information Technology System ("BMT Roadmap") in the Context of Hematopoietic Cell Transplantation (Adult Protocol)
Hematopoietic cell transplantation (BMT), or commonly referred to as blood and marrow transplantation (BMT), is a potentially life-saving therapy for many malignant and non-malignant conditions. Despite advances over the past decade, which have led to improved outcomes, BMT remains an intense treatment modality often requiring prolonged inpatient--based care. While many patients endure the acute complications of the procedure, it is common for BMT patients and their caregivers to experience increased risk of financial and emotional burden, hospital readmission, and health service utilization. This highlights the importance of active involvement of BMT patients in their own health care (self--efficacy).
Given the intense nature of BMT, however, caregivers also play a critical role in the process and are a necessary component of proceeding with transplant. As such, caregiver activation on behalf of the patient plays a critical role in effective patient--caregiver-provider partnerships, which is increasingly recognized as the optimal model for health care delivery, particularly for those facing life--altering medical treatments. It is essential to develop effective strategies to enhance this partnership. Health information technology (IT)-mediated tools offer the potential to overcome constraints in health care delivery limited by provider time, complicated health information, and financial pressures. Significant gaps in knowledge exist on the use of health IT tools using low- cost and well- accepted delivery platforms in routine inpatient care, especially for high- risk or critically ill populations. We hypothesize that a tablet--based tool displaying personal health information could provide a platform to promote caregiver activation and enhance health communication.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants will be recruited by BMT RN Coordinators and physicians prior to patient admission to the BMT Unit. Caregiver (age 18 years or older) of any patient eligible to undergo autologous or allogeneic BMT and any patient (age 18 years or older) eligible to undergo autologous or allogeneic BMT will be recruited during the "Pre-Transplant Work-up" stage in the outpatient setting.
- CAREGIVER PARTICIPANTS: Caregiver (age 18 years or older) of a patient who will be hospitalized to undergo first-time autologous (self) or allogeneic (alternative donor) BMT in the University of Michigan Mott Children's Hospital BMT Unit
- PATIENT PARTICIPANTS: Patients (age 18 years or older) who will be hospitalized to undergo first-time autologous or allogeneic BMT will be given the opportunity to assent/consent and participate in the study. With his/her permission, the patient will also be provided with their own iPad® BMT Roadmap information system to use. Qualitative interviews will be conducted in patients with their assent/consent.
- Ability to speak and read proficiently in English (the study's instruments have not been translated and validated in languages other than English)
- Willing and able to provide informed consent
- Willing to comply with study procedures and reporting requirements
Exclusion Criteria:
- Not willing and able to provide informed consent
- Not willing to comply with study procedures and reporting requirements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: BMT Roadmap
The BMT Roadmap information system will be tested in 20 caregivers of patients undergoing autologous or allogeneic BMT and in 20 patients undergoing autologous or allogeneic BMT.
|
The BMT Roadmap is a health IT System that has been developed for use on the Apple iPad® to give the patient and caregivers easy access to test results, current treatment and contact information to hopefully increase active participation and engagement in transplant care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Caregivers Accrued
Time Frame: 5 months
|
Feasibility of the study will be determined by demonstrating that accruing at least 20% of caregivers from the BMT patient population is possible.
|
5 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sung Choi, M.D., M.S., University of Michigan Rogel Cancer Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- UMCC 2015.140
- HUM00107014 (Other Identifier: University of Michigan)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients Undergoing Bone Marrow Transplant (BMT)
-
Stanford UniversityRecruitingBlood and Marrow Transplant (BMT)United States
-
Stanford UniversityCompletedGraft vs Host Disease | Blood and Marrow Transplant (BMT)United States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnCancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)
-
Technische Universität DresdenCompletedPatients Undergoing Puncture of the Bone MarrowGermany
-
Stanford UniversityCompletedBlood Cancer | Blood and Marrow Transplant (BMT)United States
-
Stanford UniversityNational Institutes of Health (NIH)CompletedMyelodysplastic Syndromes | Myeloproliferative Disorders | Myelodysplastic Syndromes (MDS) | Blood and Marrow Transplant (BMT) | Myeloproliferative Disorders (MPD)United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Duke UniversityCompletedBone Marrow Transplant
-
University of Colorado, DenverGlaxoSmithKlineRecruitingStem Cell Transplant | Bone Marrow TransplantUnited States
-
Arizona State UniversityMayo ClinicCompleted
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedBone Marrow TransplantUnited States
Clinical Trials on BMT Roadmap
-
Center for Social Innovation, MassachusettsYale UniversityCompletedMental Disorders | Behavior DisordersUnited States
-
Philips Clinical & Medical Affairs GlobalCompletedCoronary Artery DiseaseIsrael, United States, Belgium, Spain
-
Stanford UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Not yet recruitingQuality of Life | Parenthood StatusUnited States
-
University of Michigan Rogel Cancer CenterDepartment of Health and Human ServicesRecruitingHematologic DiseasesUnited States
-
National Taiwan University HospitalCompletedStroke RehabilitationTaiwan
-
West China HospitalCompleted
-
Centre Hospitalier Intercommunal CreteilAssociation pour la recherche des troubles de l'apprentissage; Orthoédition; Association... and other collaboratorsCompletedDevelopmental Disability | Learning Disorders, SpecificFrance, Martinique
-
Massachusetts General HospitalRecruitingBone Marrow Transplant ComplicationsUnited States
-
National Institutes of Health Clinical Center (CC)CompletedImage-Guided SurgeryUnited States
-
Seattle Children's HospitalNational Institutes of Health (NIH); National Center for Complementary and...CompletedAttention Deficit Hyperactivity DisorderUnited States